Focus: Sequel Med Tech is a medical device company specializing in insulin delivery systems for metabolic diseases, based in Manchester, NH. The company is developing the twiist insulin delivery system targeting Type 2 Diabetes.
Profile data last refreshed 13h ago · AI intelligence enriched 3w ago
Growing — net +5 jobs in 30d
16 jobs added vs 11 removed. Steady team buildout.
Best suited for early-career professionals seeking hands-on commercial device experience in a bootstrapped, pre-scale medical device company; risky for those prioritizing financial transparency or established R&D infrastructure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Sequel Med Tech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Sequel Med Tech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles